-
-
-
-
-
-
-
RenovoRx, Inc. (RNXT) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
RenovoRx (RNXT): Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial
-
-
-
-
-
-
-
RenovoRx (RNXT) Increases Production of FDA-Cleared RenovoCath Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
-
-
-
416,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

